Germany
Japan
United Kingdom
China
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
View as table Download
.jpg?d=110x100 "User supplied image")
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal CaMKII (Thr305) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human CaMKII around the phosphorylation site of threonine 305 (I-L-TP-T-M). |
| Modifications | Phospho-specific |
Rabbit polyclonal CDK5 (Ab-15) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human CDK5 around the phosphorylation site of tyrosine 15 (G-T-YP-G-T) |
Rabbit polyclonal MAP2K7 (Ser271) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human MAP2K7 around the phosphorylation site of serine 271 (V-D-SP-K-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal p38 MAPK (Ab-322) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human p38 MAPK around the phosphorylation site of tyreonine 322 (D-P-Y-D-Q). |
Rabbit polyclonal COT (Ab-290) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human COT around the phosphorylation site of threonine 290 (R-G-TP-E-I). |
Rabbit polyclonal Ret (Ab-905) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Ret around the phosphorylation site of tyrosine 905 (D-S-YP-V-K). |
Rabbit Polyclonal Antibody against FRAP1 (S2481)
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This mTOR (FRAP1) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 2459-2488 amino acids from human mTOR (FRAP1). |
Rabbit Polyclonal Antibody against STK39 (C-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This SPAK (STK39) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 386-415 amino acids from the C-terminal region of human SPAK (STK39). |
Rabbit anti-MAP2K4 (SEK1/MKK4, Phospho-Thr261) polyclonal antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSEK1/MKK4 around the phosphorylation site of threonine261(A-K-TP-R-D) |
| Modifications | Phospho-specific |
Rabbit polyclonal Trk B (Ab-515) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Trk B around the phosphorylation site of tyrosine 515 (P-Q-YP-F-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal MAP3K8 (Ab-400) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human MAP3K8 around the phosphorylation site of serine 400 (C-Q-SP-L-D). |
Rabbit polyclonal Raf1 (Ab-621) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human RAF1 around the phosphorylation site of serine 621 (S-A-S-E-P). |
Rabbit polyclonal Akt (Ab-129) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of serine 129 (D-N-SP-G-A). |
Rabbit polyclonal Akt (Ab-326) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of tyrosine 326 (N-D-YP-G-R). |
Rabbit polyclonal PKA alpha/beta CAT (Thr197) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PKA a/β CAT around the phosphorylation site of threonine 197 (T-W-TP-L-C). |
| Modifications | Phospho-specific |
Rabbit polyclonal GRK1 (Ab-21) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GRK1 around the phosphorylation site of serine 21 (R-G-SP-F-D) |
Active filters
Reactivities
- Rat
Applications
- IHC
Families
- Protein Kinase
Availabilities
- In Stock
Filter by
Category
Target Symbol
- MAP2K1 (69)
- ERBB2 (44)
- MAP2K3 (38)
- RET (20)
- AKT1 (19)
- MTOR (19)
- BTK (16)
- EGFR (15)
- TLK2 (14)
- BRAF (11)
- MAPK9 (11)
- FGFR2 (10)
- PRKCE (10)
- ROR2 (10)
- ALK (9)
- CHEK2 (9)
- ERBB3 (9)
- STK39 (9)
- TYRO3 (9)
- LIMK1 (8)
- MAP2K4 (8)
- MAPK1 (8)
- MARK3 (8)
- PIM2 (8)
- PTK2 (8)
- RPS6KB1 (8)
- TP53RK (8)
- MAPK13 (7)
- MET (7)
- NRBP1 (7)
- PAK1 (7)
- PLK1 (7)
- CSNK1G1 (6)
- MAP2K2 (6)
- NEK6 (6)
- NTRK1 (6)
- ACVR2A (5)
- CAMK2B (5)
- CDKL1 (5)
- FRK (5)
- MAP3K8 (5)
- MAPK8 (5)
- NTRK2 (5)
- PDGFRA (5)
- TRIM28 (5)
- AKT3 (4)
- ARAF (4)
- CDKL2 (4)
- FGFR3 (4)
- GSK3A (4)
- HIPK1 (4)
- MAK (4)
- MAP2K6 (4)
- MAPK4 (4)
- PRKD2 (4)
- RAF1 (4)
- SRC (4)
- STK38L (4)
- TRPM7 (4)
- AATK (3)
- ACVR1C (3)
- AKT2 (3)
- CDK15 (3)
- CDK5 (3)
- CSNK1A1 (3)
- CSNK1E (3)
- EIF2AK3 (3)
- JAK2 (3)
- MAPK3 (3)
- NTRK3 (3)
- PAK2 (3)
- PAK5 (3)
- PDGFRB (3)
- PIK3R4 (3)
- PRKCA (3)
- PRKD1 (3)
- PRKD3 (3)
- RPS6KA1 (3)
- TNK2 (3)
- TRIB1 (3)
- TWF1 (3)
- ADCK1 (2)
- BMPR2 (2)
- CAMK2A (2)
- CDK1 (2)
- COQ8B (2)
- CSNK1G2 (2)
- CSNK2A1 (2)
- EPHB6 (2)
- ERBB4 (2)
- GRK1 (2)
- ILK (2)
- JAK1 (2)
- MAP3K12 (2)
- MAP3K4 (2)
- MAP3K7 (2)
- MAP4K1 (2)
- MAP4K5 (2)
- MAPK12 (2)
- MAPK14 (2)
Antibody Hosts
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Pathways
- MAPK signaling pathway (312)
- Pathways in cancer (309)
- ErbB signaling pathway (293)
- Focal adhesion (252)
- Prostate cancer (230)
- Fc epsilon RI signaling pathway (229)
- Pancreatic cancer (213)
- GnRH signaling pathway (209)
- Toll-like receptor signaling pathway (199)
- Non-small cell lung cancer (195)
- Endometrial cancer (192)
- Neurotrophin signaling pathway (188)
- Glioma (186)
- Insulin signaling pathway (183)
- Colorectal cancer (181)
- Regulation of actin cytoskeleton (179)
- Progesterone-mediated oocyte maturation (171)
- Acute myeloid leukemia (169)
- Bladder cancer (169)
- Melanoma (164)
- T cell receptor signaling pathway (164)
- Chemokine signaling pathway (159)
- Fc gamma R-mediated phagocytosis (153)
- Renal cell carcinoma (153)
- VEGF signaling pathway (147)
- Chronic myeloid leukemia (141)
- B cell receptor signaling pathway (135)
- Gap junction (132)
- Vascular smooth muscle contraction (132)
- Long-term potentiation (123)
- Thyroid cancer (123)
- Natural killer cell mediated cytotoxicity (119)
- Long-term depression (114)
- Oocyte meiosis (108)
- Melanogenesis (105)
- Adherens junction (97)
- Calcium signaling pathway (96)
- Dorso-ventral axis formation (95)
- Endocytosis (95)
- Prion diseases (91)
- mTOR signaling pathway (83)
- Epithelial cell signaling in Helicobacter pylori infection (72)
- Adipocytokine signaling pathway (71)
- Axon guidance (62)
- Type II diabetes mellitus (59)
- Amyotrophic lateral sclerosis (ALS) (54)
- Tight junction (48)
- Wnt signaling pathway (47)
- Cytokine-cytokine receptor interaction (46)
- NOD-like receptor signaling pathway (42)
- TGF-beta signaling pathway (39)
- Apoptosis (38)
- Small cell lung cancer (36)
- Jak-STAT signaling pathway (32)
- RIG-I-like receptor signaling pathway (32)
- Leukocyte transendothelial migration (27)
- Cell cycle (20)
- Hedgehog signaling pathway (19)
- Alzheimer's disease (17)
- Primary immunodeficiency (16)
- Olfactory transduction (15)
- p53 signaling pathway (12)
- Vibrio cholerae infection (8)
- Pathogenic Escherichia coli infection (7)
- Regulation of autophagy (6)
- Dilated cardiomyopathy (4)
- Phosphatidylinositol signaling system (4)
- Taste transduction (4)
- Circadian rhythm - mammal (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- PPAR signaling pathway (2)
- Viral myocarditis (2)
- Cytosolic DNA-sensing pathway (1)
- Hematopoietic cell lineage (1)
- Purine metabolism (1)
- Ubiquitin mediated proteolysis (1)